Concepedia

665 A PHASE I/II STUDY OF FORETINIB, AN ORAL MULTIKINASE INHIBITOR TARGETING MET, RON, AXL, TIE-2 AND VEGFR IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

Thomas Yau, Clarence Yen, P.-J. Chen, Yat‐Pang Chau, Riccardo Lencioni, Howard Kallender, Lone H. Ottesen, Rtp Poon

Journal of Hepatology · 2011 · 10 citations · 0 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyNeoplasiaHepatocellular CarcinomaHepatocellular Carcinoma PharmacotherapyLiver CancerPharmacodynamics Of Anticancer AgentsTargeted Cancer TherapyTyrosine Kinase InhibitorsMet InhibitorsMet-targeted TherapyMultikinase Inhibitors